Mitochondrial DNA integrity and function are critical for endothelium-dependent vasodilation in rats with metabolic syndrome

• Published in: Basic research in cardiology 2022-12, Vol.117 (1), p.3-3, Article 3
• Main Authors: Kiyooka, Takahiko, Ohanyan, Vahagn, Yin, Liya, Pung, Yuh Fen, Chen, Yeong-Renn, Chen, Chwen-Lih, Kang, Patrick T., Hardwick, James P., Yun, June, Janota, Danielle, Peng, Joanna, Kolz, Christopher, Guarini, Giacinta, Wilson, Glenn, Shokolenko, Inna, Stevens, Donte A., Chilian, William M.
• Format: Article
• Language: English
• Subjects: Acetylcholine - metabolism; Acetylcholine - pharmacology; Animals; Antioxidants; ATP synthase; Cardiology; Diabetes mellitus; Dilation; DNA repair; DNA, Mitochondrial - metabolism; Electroporation; Endonuclease; Endothelial cells; Endothelial Cells - metabolism; Endothelium; Endothelium, Vascular; Exonuclease; Medicine; Medicine & Public Health; Metabolic disorders; Metabolic syndrome; Metabolic Syndrome - metabolism; Mitochondria; Mitochondria - metabolism; Mitochondrial DNA; Nitric oxide; Oligomycin; Original Contribution; Oxidative stress; Permeability; Rats; Rats, Zucker; Reduction; Vascular diseases; Vasoactive agents; Vasoactive intestinal peptide; Vasodilation
• ISSN: 0300-8428; 1435-1803
• DOI: 10.1007/s00395-021-00908-1

Endothelial dysfunction in diabetes is generally attributed to oxidative stress, but this view is challenged by observations showing antioxidants do not eliminate diabetic vasculopathy. As an alternative to oxidative stress-induced dysfunction, we interrogated if impaired mitochondrial function in endothelial cells is central to endothelial dysfunction in the metabolic syndrome. We observed reduced coronary arteriolar vasodilation to the endothelium-dependent dilator, acetylcholine (Ach), in Zucker Obese Fatty rats (ZOF, 34 ± 15% [mean ± standard deviation] 10 –3  M) compared to Zucker Lean rats (ZLN, 98 ± 11%). This reduction in dilation occurred concomitantly with mitochondrial DNA (mtDNA) strand lesions and reduced mitochondrial complex activities in the endothelium of ZOF versus ZLN. To demonstrate endothelial dysfunction is linked to impaired mitochondrial function, administration of a cell-permeable, mitochondria-directed endonuclease (mt-tat-EndoIII), to repair oxidatively modified DNA in ZOF, restored mitochondrial function and vasodilation to Ach (94 ± 13%). Conversely, administration of a cell-permeable, mitochondria-directed exonuclease (mt-tat-ExoIII) produced mtDNA strand breaks in ZLN, reduced mitochondrial complex activities and vasodilation to Ach in ZLN (42 ± 16%). To demonstrate that mitochondrial function is central to endothelium-dependent vasodilation, we introduced (via electroporation) liver mitochondria (from ZLN) into the endothelium of a mesenteric vessel from ZOF and restored endothelium-dependent dilation to vasoactive intestinal peptide (VIP at 10 –5  M, 4 ± 3% vasodilation before mitochondrial transfer and 48 ± 36% after transfer). Finally, to demonstrate mitochondrial function is key to endothelium-dependent dilation, we administered oligomycin (mitochondrial ATP synthase inhibitor) and observed a reduction in endothelium-dependent dilation. We conclude that mitochondrial function is critical for endothelium-dependent vasodilation.